Compare Home Depot Inc (HD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Zimmer Biomet Holdings Inc — how do they compare? Home Depot Inc trades at $329.65 (market cap $332.08B), while Zimmer Biomet Holdings Inc trades at $89.37 (market cap $17.36B). The key difference: Home Depot Inc is far larger — about 19.1× Zimmer Biomet Holdings Inc's market cap, and Home Depot Inc pays the higher dividend (2.8%). Which is the better fit depends on your goals.
| HD | ZBH | |
|---|---|---|
Market Cap | $332.08B | $17.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $107.71 |
52-Week Low | $297.51 | $79.58 |
Enterprise Value | $393.64B | $24.40B |
Dividend Yield | 2.8% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $331.77, down 2.1% today, with a bearish technical signal and mixed earnings history. The stock shows strong profitability with a 128.38% ROE and 8.41% net margin, but faces weakening profit margins and high valuation multiples. Recent news highlights institutional trading activity and concerns over housing market headwinds.
The outlook remains cautious due to technical weakness and margin pressure, though analyst consensus is bullish with a $370.59 price target. Key risks include rising mortgage rates impacting demand, while opportunities lie in Pro segment growth and dividend stability. The stock trades near support at $330, requiring monitoring of Q2 2026 earnings for direction.
Zimmer Biomet (ZBH) trades at $89.74, down 1.51% on the day, with a bullish technical signal from moving averages and a consensus price target of $97.67. The company reported revenue of $8.23B in 2025, with net income of $705.10M and a net margin of 8.56%. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase program, while Q2 2026 earnings are anticipated on August 5, 2026.
ZBH presents a mixed outlook with strong profitability margins and recent earnings beats offset by declining net income margins and rising debt levels. The stock offers potential upside to analyst targets but faces execution risks in competitive medical markets and macroeconomic pressures on healthcare spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
